Jack Ellis

is an Associate Researcher at Geneva Network and a freelance journalist.

Previously, Jack was the Asia-Pacific editor of Intellectual Asset Management magazine. He has also worked in a number of editorial and research roles covering intellectual property, the legal services market and the non-profit civic sector.

For more information or to contact Jack, please visit his Company Profile Page.

Recent Articles by Jack Ellis

Restricting Patents on New Combinations and Uses of Medicines Makes No Sense

IP-skeptics charge that these inventions are little more than a way for pharmaceutical companies to cynically prolong patent life and maximize profits, without providing any meaningful innovation. This rather simplistic view misunderstands how the patent system works, and the role of patents in incentivizing drug discovery and development. In reality, many of today’s most significant medicines owe their existence to the ability of medical innovators to secure patents for novel new forms and new uses of existing treatments.

July 7, 2017

View All Posts